Rein Therapeutics, Inc. Restricted Cash
Rein Therapeutics, Inc. (RNTX) had Restricted Cash of $0 as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Assets
us-gaap:RestrictedCash · last filed 2025-11-14
- 2025-09-30: Restricted Cash $0.00.
- 2025-06-30: Restricted Cash $0.00.
- 2025-03-31: Restricted Cash $0.00.
- 2024-12-31: Restricted Cash $0.00.
| Period end | Restricted Cash |
|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 |
| 2024-12-31 | $0.00 10-K · filed 2025-04-07 |
| 2024-09-30 | $25.00K 10-Q · filed 2025-11-14 |
| 2024-06-30 | $25.00K 10-Q · filed 2025-08-14 |
| 2024-03-31 | $25.00K 10-Q · filed 2025-05-15 |
| 2023-12-31 | $25.00K 10-K · filed 2025-04-07 |
| 2023-09-30 | $25.00K 10-Q · filed 2024-11-14 |
| 2023-06-30 | $25.00K 10-Q · filed 2024-08-14 |
| 2023-03-31 | $25.00K 10-Q · filed 2024-05-15 |
| 2022-12-31 | $25.00K 10-K · filed 2024-04-15 |
| 2021-12-31 | $25.00K 10-K · filed 2023-03-20 |
| 2020-12-31 | $593.00K 10-K · filed 2022-03-28 |
| 2019-12-31 | $593.00K 10-K · filed 2021-03-24 |
| 2018-12-31 | $593.00K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |